Intravitreal bevacizumab in the management of neovascular age-related macular degeneration
Purpose: To study prospectively the safety and efficacy of intravitreal bevacizumab for eyes with neovascular age-related macular degeneration with baseline visual acuity better than 70 letters (Snellen equivalent better than 20/40). Methods: Patients with treatment-naive neovascular age-related mac...
محفوظ في:
| المؤلف الرئيسي: | El-Mollayess, Georges M. (author) |
|---|---|
| مؤلفون آخرون: | Mahfoud, Ziyad (author), Schakal, Alexandre R. (author), Salti, Haytham I. (author), Jaafar, Dalida (author), Bashshur, Ziad F. (author) |
| التنسيق: | article |
| منشور في: |
2013
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/14095 https://doi.org/10.1097/IAE.0b013e3182877a0d http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.lww.com/retinajournal/Fulltext/2013/10000/INTRAVITREAL_BEVACIZUMAB_IN_THE_MANAGEMENT_OF.10.aspx |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Bevacizumab and neovascular age related macular degeneration
حسب: El Mollayess, Georges
منشور في: (2011) -
Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration
حسب: El-Mollayess, Georges M.
منشور في: (2012) -
Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?
حسب: Ghazi, Nicola G.
منشور في: (2010) -
Bevacizumab for neovascular age-related macular degeneration (ABC trial)
حسب: Ghazi, Nicola G.
منشور في: (2014) -
Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy
حسب: Ghazi, Nicola G.
منشور في: (2001)